Feedback
The current prices are delayed. Login to see live prices.
Marksans Pharma Ltd.
(MARKSANS)
201234567892012345678960123456789.0012345678950123456789
-6.64 (-2.85%)
Updated 15:56 21/02 IST
Add
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
₹224.30
Today's high
₹236.8
52 week low
₹130
52 week high
₹358.7
Open
₹233.05
Prev Close
₹232.69
Volume (shares)
953,414
Total Trading Value
22.18 Cr
Technicals
SMA
Value
Signal
12-SMA
246.7
Bearish
20-SMA
245.37
Bearish
50-SMA
266.95
Bearish
100-SMA
284.36
Bearish
200-SMA
243.69
Bearish
Discussions
• Feb 14 5:34 AM
Marksans Pharma - Quarterly Results
Earnings Update...read more
• Feb 13 3:19 AM
MARKSANS Pharma – Is the Pullback Over? Watch for the Next Move!
Hello everyone! I hope you’re all doing great! 😊 Today,...read more
• Feb 12 5:25 PM
Hello everyone! I hope you’re all doing great! 😊 Today, I’ve got an exciting setup for you – MARKSANS PHARMA! After a perio...read more
3
• Feb 12 4:15 AM
Marksans Pharma Reports Strong Q3 Financial Results with Record PAT
• Marksans Pharma achieved an all-time high quarterly PAT of Rs. 105...read more
• Feb 12 4:01 AM
Marksans Pharma Reports Strong Q3 and 9M FY2025 Financial Results
• Marksans Pharma reported Q3FY25 revenue of Rs. 681.8 cr., up 16.3%...read more
• Feb 12 3:15 AM
Marksans Pharma Q3 Financial Results Announcement
• Marksans Pharma reported a total income of approximately ₹3,343.73...read more
• Feb 12 3:01 AM
Marksans Pharma Reports Strong Financial Performance for Q3 FY2024
• Revenue from operations for Q3 FY2024 reached ₹3,118.65 million, u...read more
• Feb 12 3:01 AM
Marksans Pharma Reports Strong Q3 and Nine-Month Financial Results
• Marksans Pharma reported a 16.3% YoY revenue growth in Q3FY25, dri...read more
• Feb 12 3:01 AM
Marksans Pharma Reports Strong Financial Results for Q3 2024
• Marksans Pharma reported a revenue from operations of INR 3,118.65...read more
• Feb 12 3:01 AM
Marksans Pharma Reports No Deviation in Fund Utilization for Q4 2024
• Marksans Pharma confirms no deviation in the utilization of funds ...read more
• Feb 12 2:47 AM
Marksans Pharma's Q3 Results Showcase Strong Growth
• Marksans Pharma reported a total income of ₹3,343.73 million for Q...read more
• Feb 12 2:47 AM
Marksans Pharma Reports Strong Q3 Financial Results with Record Profit
• Marksans Pharma reported a 16.3% year-over-year revenue growth in ...read more
• Feb 12 2:47 AM
Marksans Pharma Reports Strong Q3 and Nine-Month Results for FY2024
• Marksans Pharma reported a revenue of ₹6,818.46 million for the qu...read more
• Feb 12 2:45 AM
Marksans Pharma Q3 FY25 Investor Presentation Highlights Growth Strategies
• Marksans reported a 16.3% YoY revenue increase in Q3 FY25, driven ...read more
• Feb 12 2:31 AM
Marksans Pharma Q3 and Nine-Month Results for FY 2024 Announced
• Marksans Pharma reported total income of ₹9,370.34 million for nin...read more
• Feb 10 12:30 AM
Load More Posts
Frequently Asked Questions (FAQs)
What is the Share Price of Marksans Pharma Ltd. ?
The share prices are volatile and fluctuate throughout the trading hours. The share price of Marksans Pharma Ltd. is Rs 232.69 as of 21 February 2025.
What is the Market Capitalization of Marksans Pharma Ltd. ?
The current market cap of Marksans Pharma Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.
What are the PE and PB ratios of Marksans Pharma Ltd.?
Marksans Pharma Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.
What is the 52-week high/low of Marksans Pharma Ltd.?
The 52-week high of Marksans Pharma Ltd. is Rs 358.7 and the 52-week low is Rs 130
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
FrontPage © 2025